NON-ANTIBIOTIC SUBSTANCES IN THE TREATMENT AND PREVENTION OF RECURRENT URINARY TRACT INFECTIONS

Authors

DOI:

https://doi.org/10.31435/ijitss.4(48).2025.4152

Keywords:

Recurrent Urinary Tract Infections, rUTI, Non-Antibiotic Prophylaxis, D-Mannose, Cranberry Extract, Probiotics, Vaginal Estrogen, UTI Prevention, Alternative UTI Treatment

Abstract

Urinary tract infections (UTI) create a serious health problem worldwide, affecting people of all ages. It represents one of the most common reasons for the use of antibiotics in outpatient care, leading to a reduction in their effectiveness through ever-increasing bacterial resistance to them. Thus, there is an urgent need to develop new and effective therapies. The purpose of this paper is to present alternative therapies that can help prevent and treat recurrent UTIs, such as cranberry preparations, D-mannose, robotics and topical estrogen. After analyzing the available studies, it was shown that each of these substances can have a beneficial effect on reducing recurrent UTIs, although their effectiveness varies. Substances with high therapeutic potential appear to be D-mannose and probiotics. Their action is based on supporting the natural human microflora and blocking bacterial adhesion to the epithelium of the urinary tract. A preventive strategy in the context of UTI in postmenopausal women seems to be vaginal estrogen. However, further robustly designed clinical trials need to be conducted to truly confirm that these therapies are effective and safe in terms of long-term efficacy.

References

Aggarwal N, Leslie SW. Recurrent Urinary Tract Infections. 2025 Jan 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32491411.

Cornelius SA, Basu U, Zimmern PE, De Nisco NJ. Overcoming challenges in the management of recurrent urinary tract infections. Expert Rev Anti Infect Ther. 2024 Dec;22(12):1157-1169. doi: 10.1080/14787210.2024.2412628. Epub 2024 Oct 10. PMID: 39387179; PMCID: PMC11634670..

Bono MJ, Leslie SW. Uncomplicated Urinary Tract Infections. 2025 Feb 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29261874.

Timm MR, Russell SK, Hultgren SJ. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nat Rev Microbiol. 2025 Feb;23(2):72-86. doi: 10.1038/s41579-024-01092-4. Epub 2024 Sep 9. PMID: 39251839.

Schmiemann G, Kranz J, Mandraka F, Schubert S, Wagenlehner F, Gágyor I. The Diagnosis, Treatment, and Prevention of Recurrent Urinary Tract Infection. Dtsch Arztebl Int. 2024 May 31;121(11):373-382. doi: 10.3238/arztebl.m2024.0068. PMID: 38686602; PMCID: PMC11539874.

Patel D. Intravesical Therapies for Recurrent Urinary Tract Infections: A Systematic Review. Cureus. 2024 Oct 23;16(10):e72175. doi: 10.7759/cureus.72175. PMID: 39507191; PMCID: PMC11540250.

Wawrysiuk S, Naber K, Rechberger T, Miotla P. Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance-non-antibiotic approaches: a systemic review. Arch Gynecol Obstet. 2019 Oct;300(4):821-828. doi: 10.1007/s00404-019-05256-z. Epub 2019 Jul 26. PMID: 31350663; PMCID: PMC6759629.

Habak PJ, Carlson K, Griggs, Jr RP. Urinary Tract Infection in Pregnancy. 2024 Apr 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30725732.

Pat JJ, Steffens MG, Witte LPW, Marcelissen TAT, Blanker MH. Comparison of the diagnostic yield of routine versus indicated flowmetry, ultrasound and cystoscopy in women with recurrent urinary tract infections. Int Urogynecol J. 2022 Aug;33(8):2283-2289. doi: 10.1007/s00192-021-04871-2. Epub 2021 Jun 14. PMID: 34125244; PMCID: PMC9343267.

Shi L, Ren J, Jin K, Li J. Depression and risk of infectious diseases: A mendelian randomization study. Transl Psychiatry. 2024 Jun 8;14(1):245. doi: 10.1038/s41398-024-02950-8. PMID: 38851830; PMCID: PMC11162453

McLellan LK, Hunstad DA. Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol Med. 2016 Nov;22(11):946-957. doi: 10.1016/j.molmed.2016.09.003. Epub 2016 Sep 28. PMID: 27692880; PMCID: PMC5159206.

Jangid H, Shidiki A, Kumar G. Cranberry-derived bioactives for the prevention and treatment of urinary tract infections: antimicrobial mechanisms and global research trends in nutraceutical applications. Front Nutr. 2025 Feb 26;12:1502720. doi: 10.3389/fnut.2025.1502720. PMID: 40078413; PMCID: PMC11896822.

González de Llano D, Roldán M, Taladrid D, Relaño de la Guía E, Moreno-Arribas MV, Bartolomé B. Cranberry Polyphenols and Prevention against Urinary Tract Infections: New Findings Related to the Integrity and Functionality of Intestinal and Urinary Barriers. J Agric Food Chem. 2024 May 8;72(18):10328-10338. doi: 10.1021/acs.jafc.3c07169. Epub 2024 Apr 23. PMID: 38651941; PMCID: PMC11082924.

Ioannou P, Baliou S. The Molecular Mechanisms and Therapeutic Potential of Cranberry, D-Mannose, and Flavonoids against Infectious Diseases: The Example of Urinary Tract Infections. Antibiotics (Basel). 2024 Jun 26;13(7):593. doi: 10.3390/antibiotics13070593. PMID: 39061275; PMCID: PMC11273536.

Kyriakides R, Jones P, Somani BK. Role of D-Mannose in the Prevention of Recurrent Urinary Tract Infections: Evidence from a Systematic Review of the Literature. Eur Urol Focus. 2021 Sep;7(5):1166-1169. doi: 10.1016/j.euf.2020.09.004. Epub 2020 Sep 22. PMID: 32972899.

Hayward G, Mort S, Hay AD, Moore M, Thomas NPB, Cook J, Robinson J, Williams N, Maeder N, Edeson R, Franssen M, Grabey J, Glogowska M, Yang Y, Allen J, Butler CC. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial. JAMA Intern Med. 2024 Jun 1;184(6):619-628. doi: 10.1001/jamainternmed.2024.0264. PMID: 38587819; PMCID: PMC11002776.

Ala-Jaakkola R, Laitila A, Ouwehand AC, Lehtoranta L. Role of D-mannose in urinary tract infections - a narrative review. Nutr J. 2022 Mar 22;21(1):18. doi: 10.1186/s12937-022-00769-x. PMID: 35313893; PMCID: PMC8939087.

Konesan J, Liu L, Mansfield KJ. The Clinical Trial Outcomes of Cranberry, D-Mannose and NSAIDs in the Prevention or Management of Uncomplicated Urinary Tract Infections in Women: A Systematic Review. Pathogens. 2022 Dec 5;11(12):1471. doi: 10.3390/pathogens11121471. PMID: 36558804; PMCID: PMC9788503.

Parazzini F, Ricci E, Fedele F, Chiaffarino F, Esposito G, Cipriani S. Systematic review of the effect of D-mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review). Biomed Rep. 2022 Jun 15;17(2):69. doi: 10.3892/br.2022.1552. PMID: 35815191; PMCID: PMC9260159.

Choi J, Thänert R, Reske KA, Nickel KB, Olsen MA, Hink T, Thänert A, Wallace MA, Wang B, Cass C, Barlet MH, Struttmann EL, Iqbal ZH, Sax SR, Fraser VJ, Baker AW, Foy KR, Williams B, Xu B, Capocci-Tolomeo P, Lautenbach E, Burnham CD, Dubberke ER, Dantas G, Kwon JH; CDC Prevention Epicenters Program. Gut microbiome correlates of recurrent urinary tract infection: a longitudinal, multi-center study. EClinicalMedicine. 2024 Apr 26;71:102490. doi: 10.1016/j.eclinm.2024.102490. PMID: 38813445; PMCID: PMC11133793.

Nelwan EJ, Herdiman A, Kalaij AGI, Lauditta RK, Yusuf SM, Suarthana E. Role of probiotic as adjuvant in treating various infections: a systematic review and meta-analysis. BMC Infect Dis. 2024 May 21;24(1):505. doi: 10.1186/s12879-024-09259-3. PMID: 38773400; PMCID: PMC11106949.

Neugent ML, Hulyalkar NV, Nguyen VH, Zimmern PE, De Nisco NJ. Advances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection. mBio. 2020 Apr 28;11(2):e00218-20. doi: 10.1128/mBio.00218-20. PMID: 32345639; PMCID: PMC7188990..

Chen YC, Lee WC, Chuang YC. Emerging Non-Antibiotic Options Targeting Uropathogenic Mechanisms for Recurrent Uncomplicated Urinary Tract Infection. Int J Mol Sci. 2023 Apr 11;24(8):7055. doi: 10.3390/ijms24087055. PMID: 37108218; PMCID: PMC10138837.

Young MG, Straub TJ, Worby CJ, Metsky HC, Gnirke A, Bronson RA, van Dijk LR, Desjardins CA, Matranga C, Qu J, Villicana JB, Azimzadeh P, Kau A, Dodson KW, Schreiber HL 4th, Manson AL, Hultgren SJ, Earl AM. Distinct Escherichia coli transcriptional profiles in the guts of recurrent UTI sufferers revealed by pangenome hybrid selection. Nat Commun. 2024 Nov 2;15(1):9466. doi: 10.1038/s41467-024-53829-7. PMID: 39487120; PMCID: PMC11530686.

Vaughan MH, Mao J, Karstens LA, Ma L, Amundsen CL, Schmader KE, Siddiqui NY. The Urinary Microbiome in Postmenopausal Women with Recurrent Urinary Tract Infections. J Urol. 2021 Nov;206(5):1222-1231. doi: 10.1097/JU.0000000000001940. Epub 2021 Jun 28. PMID: 34181466; PMCID: PMC8497440.

Jung C, Brubaker L. The etiology and management of recurrent urinary tract infections in postmenopausal women. Climacteric. 2019 Jun;22(3):242-249. doi: 10.1080/13697137.2018.1551871. Epub 2019 Jan 9. PMID: 30624087; PMCID: PMC6629580.

Davis SR, Pinkerton J, Santoro N, Simoncini T. Menopause-Biology, consequences, supportive care, and therapeutic options. Cell. 2023 Sep 14;186(19):4038-4058. doi: 10.1016/j.cell.2023.08.016. Epub 2023 Sep 6. PMID: 37678251.

Anglim B, Phillips C, Shynlova O, Alarab M. The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections. Int Urogynecol J. 2022 Aug;33(8):2107-2117. doi: 10.1007/s00192-021-04832-9. Epub 2021 May 18. PMID: 34003309.

Tan-Kim J, Shah NM, Do D, Menefee SA. Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women. Am J Obstet Gynecol. 2023 Aug;229(2):143.e1-143.e9. doi: 10.1016/j.ajog.2023.05.002. Epub 2023 May 11. PMID: 37178856.

Downloads

Published

2025-12-25

How to Cite

NON-ANTIBIOTIC SUBSTANCES IN THE TREATMENT AND PREVENTION OF RECURRENT URINARY TRACT INFECTIONS. (2025). International Journal of Innovative Technologies in Social Science, 4(4(48). https://doi.org/10.31435/ijitss.4(48).2025.4152

Most read articles by the same author(s)